Status:
RECRUITING
Oncoliq: Test for Early Breast Cancer Detection.
Lead Sponsor:
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Collaborating Sponsors:
Instituto Nacional del Cáncer, Argentina
Conditions:
Breast Cancer
Eligibility:
FEMALE
50-70 years
Brief Summary
Oncoliq is a novel early breast cancer detection test based on liquid biopsies and microRNAs. This innovative test will allow improving the accuracy of cancer detection which will impact on health, re...
Eligibility Criteria
Inclusion
- Women patients performing gynecological control
- Between 50-70 years old
- Without personal history of oncological disease
- Informed consent signed
Exclusion
- Patients who don´t meet the inclusion criteria.
- Active infection with SARS-CoV-2 (COVID-19).
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04906330
Start Date
September 1 2021
End Date
August 1 2025
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Militar Central
CABA, Buenos Aires, Argentina, C1426BOR